Assertio Therapeutics Announces Completion and Final Results of the Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes due 2021 and 5.00% Senior Convertible...
Assertio Holdings, Inc. (ASRT)
Last assertio holdings, inc. earnings: 3/9 04:02 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
LAKE FOREST, Ill., April 08, 2020 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), today announced the completion and final results for its cash tender offers (the “Offers”) to purchase any and all of the outstanding $42,465,000 in aggregate principal amount of its 2.50% Senior Convertible Notes due 2021 (CUSIP: 249908AA2) (“2021 Notes”) and $34,522,000 of its 5.00% Senior Convertible Notes due 2024 (CUSIP: 04545LAA5) (“2024 Notes”, together with the 2021 Notes, the “Notes”). The Offers were made on the terms and subject to the conditions set forth in an Offer to Purchase dated March 11, 2020 (the “Offer to Purchase”) and expired at 11:59 p.m., New York City time, on April 7, 2020 (the “Expiration Time”). As of the Expiration Time of the Offers, $42,130,000 aggregate principal of 2021 Notes and $34,522,000 aggregate principal of 2024 Notes have been validly tendered and not validly withdrawn (the “Accepted Notes”). Holders of the Accept
Show less
Read more
Impact Snapshot
Event Time:
ASRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASRT alerts
High impacting Assertio Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ASRT
News
- Quetzal Therapeutics Appoints Todd Smith as Board Member [Yahoo! Finance]Yahoo! Finance
- Assertio Holdings Inc (ASRT) Q3 2025 Earnings Call Highlights: Impressive Growth Amid Market ... [Yahoo! Finance]Yahoo! Finance
- Assertio Holdings, Inc. (ASRT) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Assertio stock rises after revenue beat [Seeking Alpha]Seeking Alpha
- Assertio Reports Third Quarter 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
ASRT
Earnings
- 11/10/25 - Beat
ASRT
Sec Filings
- 11/21/25 - Form 8-K
- 11/14/25 - Form 4
- 11/12/25 - Form 4
- ASRT's page on the SEC website